https://www.indianpharmapost.com/aarti-drugs-posts-q2-fy25-consolidated-profit-at-rs-3501-cr-163632024-10-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-life-sciences-posts-q2-fy25-net-profit-at-rs-9531-cr-163642024-10-26T00:00:00+05:30always0.9